tiprankstipranks
Trending News
More News >
Pharmaron Beijing Co., Ltd. Class H (HK:3759)
:3759

Compare Pharmaron Beijing Co., Ltd. Class H (3759) vs. Competitors

Compare
10 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Pharmaron Beijing Co., Ltd. Class H
HK$24.14
HK$55.94B
22.32
46.67%
4 Buy
0 Hold
0 Sell
Strong Buy
Genscript Biotech
HK$14.33
HK$27.95B
20.32%
2 Buy
0 Hold
0 Sell
Moderate Buy
Zai Lab Ltd
HK$22.18
HK$14.67B
-8.64
-37.18%
6 Buy
2 Hold
0 Sell
Strong Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$21.38
HK$36.44B
-20.84
94.36%
0 Buy
1 Hold
0 Sell
Hold
Simcere Pharmaceutical Group Limited
HK$11.69
HK$30.34B
30.28
70.66%
2 Buy
0 Hold
0 Sell
Moderate Buy
Asymchem Laboratories (Tianjin) Co., Ltd. Class H
HK$73.80
HK$39.21B
25.95
64.55%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:3759
Pharmaron Beijing Co., Ltd. Class H
20.68
6.86
49.68%
HK:1548
Genscript Biotech
12.85
2.33
22.15%
HK:9688
Zai Lab Ltd
13.13
-7.72
-37.03%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
21.38
10.78
101.70%
HK:2096
Simcere Pharmaceutical Group Limited
11.69
4.88
71.66%
HK:6821
Asymchem Laboratories (Tianjin) Co., Ltd. Class H
81.45
32.50
66.39%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts